window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Therapeutic Areas

  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Therapeutic Areas

    Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing

    Just – Evotec Biologics has been selected by BARDA to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Therapeutic Areas

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    Mestag Therapeutics has raised $40 million and appointed two senior [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    PolyPid prepares D-PLEX100 NDA following Phase 3 surgical infection data

    PolyPid is preparing to submit a New Drug Application for [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    One-carbon partners Tempus to support TH9619 development in solid tumours

    One-carbon Therapeutics has signed a collaboration with Tempus to generate [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Hemab Therapeutics wins FDA breakthrough therapy status for sutacimig in Glanzmann thrombasthenia

      The FDA has granted breakthrough therapy designation to Hemab [...]

    May 5, 2026
  • Digital & Data,Therapeutic Areas

    Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies

    Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Therapeutic Areas

    Laser therapy reduces bacterial load in burn wounds, study shows

    A single photobiomodulation session reduced bacterial load in acute burn [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    Ethris part of EU consortium to advance novel pandemic influenza vaccine

    Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

    As Rare Disease Day 2026 shines a spotlight on patients [...]

    May 5, 2026
  • Therapeutic Areas

    Rare Disease Day 2026: Er-Kim pushes to close access gap in underserved markets

    As Rare Disease Day 2026 highlights the challenges faced by [...]

    May 5, 2026
Previous212223Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Limbic selected for FDA pilot to test AI-led mental healthcare
    Categories: Central Nervous System, Clinical & Regulatory, Digital & Data, Pharmaceuticals and therapeutics, Therapeutic Areas
  • APAC ablation catheter market set to grow 14% as pulsed field ablation gains ground
    Categories: Medical devices
  • Andelyn and Queen’s University partner on AAV9 gene therapy for GM2 gangliosidoses
    Categories: Advanced Therapies, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top